nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—Dexmethylphenidate—SLC6A4—conduct disorder	0.114	0.5	CrCbGaD
Ipratropium bromide—Methylphenidate—SLC6A4—conduct disorder	0.114	0.5	CrCbGaD
Ipratropium bromide—CHRM5—Monoamine GPCRs—DRD4—conduct disorder	0.0351	0.0455	CbGpPWpGaD
Ipratropium bromide—CHRM5—Amine ligand-binding receptors—DRD4—conduct disorder	0.0295	0.0382	CbGpPWpGaD
Ipratropium bromide—CHRM1—Monoamine GPCRs—DRD4—conduct disorder	0.0247	0.032	CbGpPWpGaD
Ipratropium bromide—CHRM3—Monoamine GPCRs—DRD4—conduct disorder	0.0246	0.0319	CbGpPWpGaD
Ipratropium bromide—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.0244	0.0316	CbGpPWpGaD
Ipratropium bromide—CHRM5—Monoamine GPCRs—HTR2A—conduct disorder	0.0229	0.0297	CbGpPWpGaD
Ipratropium bromide—CHRM1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0208	0.0269	CbGpPWpGaD
Ipratropium bromide—CHRM3—Amine ligand-binding receptors—DRD4—conduct disorder	0.0207	0.0268	CbGpPWpGaD
Ipratropium bromide—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0205	0.0266	CbGpPWpGaD
Ipratropium bromide—CHRM5—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0192	0.0249	CbGpPWpGaD
Ipratropium bromide—CHRM1—Monoamine GPCRs—HTR2A—conduct disorder	0.0161	0.0209	CbGpPWpGaD
Ipratropium bromide—CHRM3—Monoamine GPCRs—HTR2A—conduct disorder	0.0161	0.0208	CbGpPWpGaD
Ipratropium bromide—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.0159	0.0206	CbGpPWpGaD
Ipratropium bromide—CHRM5—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.015	0.0195	CbGpPWpGaD
Ipratropium bromide—CHRM1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0136	0.0176	CbGpPWpGaD
Ipratropium bromide—CHRM3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0135	0.0175	CbGpPWpGaD
Ipratropium bromide—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0134	0.0173	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0131	0.0169	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0126	0.0163	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Other—DRD4—conduct disorder	0.0109	0.0142	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.0108	0.014	CbGpPWpGaD
Ipratropium bromide—CHRM1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0106	0.0137	CbGpPWpGaD
Ipratropium bromide—CHRM3—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0106	0.0137	CbGpPWpGaD
Ipratropium bromide—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0105	0.0135	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0104	0.0134	CbGpPWpGaD
Ipratropium bromide—SLC22A4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00987	0.0128	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—CGA—conduct disorder	0.00789	0.0102	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00749	0.0097	CbGpPWpGaD
Ipratropium bromide—SLC22A5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00742	0.00961	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0073	0.00945	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00727	0.00942	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0072	0.00933	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Other—HTR2A—conduct disorder	0.00714	0.00925	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.00707	0.00916	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00677	0.00877	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—SLC6A4—conduct disorder	0.00619	0.00802	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00592	0.00767	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.00582	0.00754	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0058	0.00752	CbGpPWpGaD
Ipratropium bromide—CHRM5—G alpha (q) signalling events—HTR2A—conduct disorder	0.00572	0.00741	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00563	0.0073	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.00556	0.0072	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—CGA—conduct disorder	0.00554	0.00718	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.00548	0.00711	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00511	0.00662	CbGpPWpGaD
Ipratropium bromide—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.00507	0.00657	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00477	0.00618	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00475	0.00616	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00471	0.0061	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00459	0.00595	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—CGA—conduct disorder	0.00446	0.00578	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00442	0.00573	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—DRD4—conduct disorder	0.00442	0.00572	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00409	0.00529	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00407	0.00528	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CGA—conduct disorder	0.00405	0.00525	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00403	0.00523	CbGpPWpGaD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00403	0.00521	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—HTR2A—conduct disorder	0.00401	0.0052	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00387	0.00502	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00379	0.00491	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.0036	0.00466	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00359	0.00465	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00317	0.00411	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00315	0.00408	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.00314	0.00407	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CGA—conduct disorder	0.00313	0.00405	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00313	0.00405	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00311	0.00403	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.00311	0.00403	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0031	0.00402	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—DRD4—conduct disorder	0.0031	0.00402	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.0031	0.00402	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00307	0.00398	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.00307	0.00398	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	0.00288	0.00374	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.00285	0.00369	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CGA—conduct disorder	0.00284	0.00368	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00281	0.00365	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00267	0.00345	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00266	0.00344	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00263	0.00341	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	0.0025	0.00324	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00243	0.00315	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CGA—conduct disorder	0.00239	0.0031	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—DRD4—conduct disorder	0.00227	0.00294	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00207	0.00268	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00206	0.00267	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00204	0.00265	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	0.00203	0.00263	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	0.00202	0.00262	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—EP300—conduct disorder	0.00201	0.00261	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CGA—conduct disorder	0.00201	0.0026	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.002	0.0026	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—WASF1—conduct disorder	0.00192	0.00248	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	0.00176	0.00228	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	0.00175	0.00227	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.00174	0.00225	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CGA—conduct disorder	0.00168	0.00218	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CGA—conduct disorder	0.00168	0.00218	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CGA—conduct disorder	0.00166	0.00215	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	0.00163	0.00211	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—DRD4—conduct disorder	0.0016	0.00207	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—DRD4—conduct disorder	0.00159	0.00206	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.00158	0.00204	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	0.00148	0.00192	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—WASF1—conduct disorder	0.00135	0.00175	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—WASF1—conduct disorder	0.00135	0.00174	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—DRD4—conduct disorder	0.00134	0.00174	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.00133	0.00173	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CGA—conduct disorder	0.0012	0.00156	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	0.00115	0.00149	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	0.00114	0.00148	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.00113	0.00147	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	0.00104	0.00135	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	0.00104	0.00135	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.00103	0.00133	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DRD4—conduct disorder	0.000943	0.00122	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DRD4—conduct disorder	0.00094	0.00122	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.000931	0.00121	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—COMT—conduct disorder	0.000906	0.00117	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MAOA—conduct disorder	0.0009	0.00117	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HTR2A—conduct disorder	0.000874	0.00113	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CGA—conduct disorder	0.000785	0.00102	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR2A—conduct disorder	0.000615	0.000797	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR2A—conduct disorder	0.000613	0.000795	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.000607	0.000787	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—COMT—conduct disorder	0.000542	0.000702	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MAOA—conduct disorder	0.000538	0.000697	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EP300—conduct disorder	0.000463	0.0006	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—EP300—conduct disorder	0.000389	0.000504	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—COMT—conduct disorder	0.000354	0.000459	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MAOA—conduct disorder	0.000352	0.000456	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EP300—conduct disorder	0.000326	0.000422	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EP300—conduct disorder	0.000325	0.000421	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EP300—conduct disorder	0.000322	0.000417	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—EP300—conduct disorder	0.000232	0.000301	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—EP300—conduct disorder	0.000152	0.000197	CbGpPWpGaD
